The human microbiome is no longer a peripheral interest in medicine; it has become a central frontier for therapeutic innovation. As the "second genome," the gut microbiota dictates systemic immune responses, metabolic homeostasis, and even neurological health. For drug developers and academic researchers, harnessing this complex ecosystem requires more than just high-throughput sequencing; it demands a sophisticated, end-to-end preclinical strategy.
As a leading Contract Research Organization (CRO) specializing in microbiome-driven drug development, Creative Biolabs provides the specialized infrastructure and scientific expertise necessary to bridge the gap between initial discovery and clinical readiness. Our Preclinical Microbiome Transplantation and Gut Engineering Service is designed to transform complex biological hypotheses into validated, reproducible therapeutic candidates. Whether you are developing Live Biotherapeutic Products (LBPs), exploring Fecal Microbiota Transplantation (FMT) protocols, or engineering synthetic microbial communities, our platform offers the precision and scalability required to navigate the rigorous demands of preclinical drug development.
Overview: Preclinical Microbiome Transplantation & Gut Engineering
The core of our service lies in the ability to manipulate, replace, or enhance the microbial ecosystem within high-fidelity animal models. Microbiome transplantation is a delicate process that involves the transfer of curated microbial communities, derived from human donors, diseased cohorts, or synthetic consortia, into germ-free or antibiotic-depleted recipients.
Our approach goes beyond simple "transfer." We focus on Gut Microbiome Engineering, which involves the strategic modification of the gut environment to favor the engraftment of beneficial strains or the exclusion of pathogens. This includes the use of precision prebiotics, engineered niches, and modified microbial strains. By integrating these techniques, we help our partners establish clear causal links between specific microbial signatures and therapeutic outcomes.
Service Portfolio
Our services are structured to support every phase of the preclinical pipeline, ensuring that each variable, from donor screening to metabolic profiling, is meticulously controlled.
Advanced Microbiome Transplantation (FMT & SMT)
We offer both Fecal Microbiota Transplantation (FMT) and Synthetic Microbiota Transplantation (SMT). While FMT uses complex, donor-derived samples to replicate a "complete" ecosystem, SMT utilizes defined, lab-grown consortia of characterized strains. This allows for higher reproducibility and a clearer understanding of which specific microbes are driving the observed phenotype.
Germ-Free and Gnotobiotic Animal Services
The gold standard for microbiome research is the gnotobiotic model. We maintain a state-of-the-art facility featuring germ-free (GF) mice and rats. These animals are reared in sterile isolators, allowing us to "build" a microbiome from scratch. This enables researchers to study the impact of a single strain or a complex community without the interference of indigenous microbes.
Gut Microbiota Engineering and Niche Colonization
We utilize specialized protocols to enhance the engraftment of your therapeutic candidates. This includes the development of "niche-clearing" antibiotic cocktails and the formulation of specialized diets that provide a competitive advantage to the transplanted taxa. We also provide services for the colonization of specific mucosal sites, ensuring that the biotherapeutics reach their intended target, whether it be the small intestine or the distal colon.
Longitudinal Multi-Omics Profiling
To understand the "how" behind the results, we provide deep molecular insights. Our platform integrates:
-
16S rRNA and Shotgun Metagenomics: To track the engraftment and stability of the transplanted species.
-
Metatranscriptomics: To observe the functional gene expression of the microbes in situ.
-
Metabolomics: To measure the production of Short-Chain Fatty Acids (SCFAs), bile acids, and other bioactive metabolites that influence host health.
Related Products for Preclinical Studies
To support our CRO services, we provide a catalog of high-quality products designed specifically for microbiome research environments.
-
Standardized Human Fecal Microbiota: Pre-screened, high-diversity fecal material from healthy human donors, processed under strict anaerobic conditions and available in various formats (frozen, lyophilized, or glycerol-stocked).
-
Defined Microbial Consortia: Pre-mixed "cocktails" of common gut commensals used as standardized benchmarks in microbiome experiments.
Application Fields
Our Preclinical Microbiome Transplantation service is utilized across a diverse range of therapeutic areas:
-
Immuno-Oncology: Investigating how the microbiome modulates the efficacy of immune checkpoint inhibitors (ICIs) and developing "responder" signatures.
-
Metabolic Diseases: Studying the role of the gut-liver axis in NAFLD/NASH and the impact of microbial metabolites on insulin sensitivity.
-
Neurological Disorders (Gut-Brain Axis): Exploring the microbial influence on neuroinflammation in models of Parkinson's, Alzheimer's, and Autism Spectrum Disorder (ASD).
-
Inflammatory Bowel Disease (IBD): Validating the anti-inflammatory properties of novel probiotics or engineered microbes in DSS or TNBS-induced colitis models.
-
Infectious Disease: Developing biotherapeutics to combat antibiotic-resistant pathogens like Clostridioides difficile.
Our Platform Advantages
Choosing a CRO partner for microbiome research requires trust in their technical precision and regulatory understanding. Our platform is built on four pillars:
Absolute Anaerobic Integrity
Over 90% of the gut microbiota are obligate anaerobes. Even brief exposure to oxygen can lead to the loss of key therapeutic species. Our entire workflow, from sample processing to transplantation, occurs within advanced anaerobic chambers, ensuring that the "live" in Live Biotherapeutics is never compromised.
Standardized, Reproducible Models
The "batch effect" is a common hurdle in microbiome studies. We minimize variability by using standardized donor material, synchronized animal cohorts, and strictly controlled environmental parameters (humidity, light cycles, and sterile diet).
Integrated Bioinformatics Pipeline
Data is only as good as the analysis. Our proprietary bioinformatics platform is tailored for gnotobiotic data, allowing for the easy subtraction of host DNA and the precise identification of low-abundance strains that might be missed by standard pipelines.
Regulatory-Ready Documentation
As a CRO focused on drug development, we maintain rigorous documentation standards. Every step of our process is tracked, providing you with the high-quality data packages required for Investigational New Drug (IND) filings.
Partnering for the Future of Medicine
The path to a successful microbiome-based therapy is paved with complex biological questions. Is the strain engrafting? Is it producing the right metabolites? Is it safe? At Creative Biolabs, we don't just provide data; we provide answers. By combining cutting-edge gnotobiotic facilities with deep ecological expertise, we empower your team to push the boundaries of what is possible in drug development.
We invite you to reach out to our scientific consultants to discuss your specific project goals. Together, we can engineer the next generation of therapies, one microbe at a time. Whether you are a startup at the seed stage or a global pharmaceutical leader, our Preclinical Microbiome Transplantation and Gut Engineering Service is the robust foundation your research deserves.
Contact our scientific team today to discuss your project specifications and let us help you engineer the future of human health.
Frequently Asked Questions (FAQs)
How do you ensure the stability of the microbiome after transplantation?
We monitor stability through longitudinal fecal sampling and 16S sequencing at multiple time points post-transplantation. Additionally, we can provide "booster" doses if a study design requires prolonged colonization of transient strains.
What animal species are available for transplantation?
While C57BL/6 and BALB/c mice are the most common models, we also offer services in rats. We can also discuss customized models if your research targets a specific genetic background.
How long does a typical transplantation study take?
A standard pilot study, including animal acclimation, antibiotic clearing (if necessary), transplantation, and four weeks of monitoring, typically spans 8 to 12 weeks.
